Koate-DVI human and Oxybutynin Extended-Release Tablets
Determining the interaction of Koate-DVI human and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Koate-DVI (human)
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Koate-DVI human-Oxybutynin Gel
- Koate-DVI human-Oxybutynin Oral Solution
- Koate-DVI human-Oxybutynin Syrup
- Koate-DVI human-Oxybutynin Tablets
- Koate-DVI human-Oxybutynin transdermal
- Koate-DVI human-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Kogenate FS
- Oxybutynin Extended-Release Tablets-Kogenate FS Bio-Set
- Oxybutynin Extended-Release Tablets-Kogenate FS recombinant
- Oxybutynin Extended-Release Tablets-Kola-Pectin
- Oxybutynin Extended-Release Tablets-Kola-Pectin DS
- Oxybutynin Extended-Release Tablets-Kolephrin